Back to search

Article

Protein-losing enteropathy as a new phenotype in atypical hemolytic uremic syndrome caused by CD46 gene mutation and recovery from chronic kidney failure by eculizumab treatment

2024-03-12

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Atypical hemolytic uremic syndrome (aHUS) is a life-threatening thrombotic microangiopathies. Genetic defects in complement alternative pathway have been identified in 60-70% of aHUS individuals. Eculizumab is recommended as first-line therapy. <bold>Methods</bold>: We collected clinical data of a pediatric aHUS case, who accompanied with protein-losing enteropa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
83097d97-e3d2-5777-b782-e9b901cc5bc7
DOI
10.21203/rs.3.rs-4019102/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Protein-losing enteropathy as a new phenotype in atypical hemolytic uremic syndrome caused by CD46 gene mutation and recovery from chronic kidney failure by eculizumab treatmentDOI 10.21203/rs.3.rs-4019102/v1
Select a neighboring publication to make it the new centre.